Workflow
Merit Financial Advisors buys Yeomans Consulting Group
Yahoo Finance· 2026-03-12 12:01
Acquisition Overview - Merit Financial Advisors has acquired Yeomans Consulting Group, a wealth management firm based in Marietta, Georgia, for an undisclosed sum, adding approximately $434 million in assets to Merit's portfolio [1] - This acquisition marks Merit's fifty-sixth acquisition, following the recent purchase of Glenn Co, which added about $208 million in assets [2] Strategic Implications - The deal is expected to enable accelerated growth, operational stability, and support for Yeomans, with both Randy and Nicholas Yeomans becoming wealth managers and partners at Merit [1][2] - The acquisition aligns with Merit's commitment to strategic growth and the expansion of its partnership with SEI [3] Team Integration - Yeomans' operations, compliance, and client service teams will also join Merit, enhancing the overall capabilities for clients and providing growth opportunities for staff [2][4] - Both Randy and Nicholas Yeomans expressed enthusiasm about the partnership, highlighting the cultural alignment and the benefits for clients and team members [2] Company Profile - Merit is headquartered in Atlanta, Georgia, and managed $24.69 billion in assets as of January 1, 2026, operating more than 55 offices across the United States [3]
BIO-key Partners with TD SYNNEX Public Sector (DLT) to Deliver Identity-Bound Biometric and IAM Solutions to the U.S. Public Sector
Globenewswire· 2026-03-12 11:57
Core Insights - BIO-key International, Inc. has formed a strategic partnership with TD SYNNEX Public Sector to enhance identity and access management solutions for government agencies [1][2][4] Group 1: Partnership Details - The partnership aims to provide a streamlined procurement path for government entities to adopt Zero Trust architectures and phishing-resistant multi-factor authentication [2] - BIO-key's PortalGuard IAM platform and Passkey:YOU™ biometric solutions will be integrated into DLT's portfolio, facilitating easier deployment of identity security solutions [2][3] Group 2: Strategic Importance - This collaboration is seen as a significant milestone for BIO-key in advancing its mission to enhance government security through Identity-Bound Biometrics [4] - The partnership is expected to improve cybersecurity posture, reduce risk, and provide secure access to critical systems for government agencies [4][5] Group 3: Technical Capabilities - Key capabilities offered through the partnership include compliance with various regulations such as Criminal Justice Information Services (CJIS), HIPAA, and NIST SP 800-171 [3] - BIO-key's solutions include identity-bound biometrics, centralized control via the PortalGuard platform, and support for over twenty authentication methods [7][8]
Texas ETFs: Investing in the Lone Star Economy
Etftrends· 2026-03-12 11:56
Core Insights - Texas is increasingly recognized for its economic advantages, with a GDP of $2.77 trillion in 2024 and leading the nation by adding 132,500 jobs in 2025, making it the eighth largest economy globally, surpassing countries like Canada and South Korea [1][2] Economic Overview - Texas has a pro-business environment characterized by no personal or corporate income tax, a low-cost operating environment, and a significant presence of major employers, including 54 Fortune 500 companies and over 3.5 million small businesses [1] - The Texas Stock Exchange is set to launch trading in 2026, indicating the state's ambitions in capital markets [1] Texas ETF Landscape - Four ETFs currently target the Texas economy, including two diversified funds and two focused on energy [1] - The Texas Capital Texas Equity Index ETF (TXS) is the oldest Texas ETF, launched in July 2023, with $34 million in assets, and has a diversified portfolio with a 22% weight in energy [1] - The Texas Capital Texas Oil Index ETF (OILT) tracks companies involved in oil and gas extraction in Texas, with a unique weighting methodology based on production rather than market cap, and has seen a 29% increase this year [1] - The iShares Texas Equity ETF (TEXN), launched in June 2025, has a more energy-tilted portfolio with 38% in energy and the lowest expense ratio among the group at 20 basis points [1] - The Horizon Kinetics Texas ETF (TEXX), launched in 2026, is actively managed and focuses on companies benefiting from Texas's economic expansion, with over 50% of its holdings in the energy sector [1] Investment Implications - Texas ETFs provide a focused investment opportunity in one of the fastest-growing state economies in the U.S., appealing to investors looking for both broad equity exposure and specialized industry investments [2] - The size of the Texas economy positions it as a viable alternative to single-country ETFs, making Texas ETFs a complementary addition to a broader U.S. equity portfolio [2]
Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026
Prnewswire· 2026-03-12 11:55
Core Insights - Syra Health reported a strong financial performance for FY2025, with a 157% growth in population health revenue and a 76% reduction in net loss, targeting profitability by the end of 2026 [1][2] Financial Performance - Population health revenue increased to $5.3 million in FY2025 from $2.1 million in FY2024, marking a 157% year-over-year growth [1] - Total revenue for FY2025 was $7.2 million, a 9% decrease from $8.0 million in FY2024, primarily due to reduced federal government funding [1][2] - Net loss improved to ($896K) in FY2025 from ($3.8M) in FY2024, reflecting a 76% reduction [1][2] - Earnings per share (EPS) improved to ($0.08) in FY2025 from ($0.50) in FY2024 [1] - Gross margin increased to 34.4% in FY2025 from 20.7% in FY2024, a 14 percentage point rise attributed to better operational efficiency [1] Operational Highlights - Operating expenses decreased by 37% to $3.4 million in FY2025 compared to $5.4 million in FY2024 [1] - The company launched a wellness pilot program in collaboration with a public health department in North Carolina [1] - Syra Health submitted Syrenity for FDA approval under the TEMPO pilot program, aiming to participate in CMS's ACCESS Model starting July 2026 [1] Future Outlook - The company anticipates achieving profitability by year-end 2026, driven by strong demand for its population health solutions and disciplined cost management [1] - Management expressed confidence in the company's path to profitability, highlighting the combination of revenue growth and cost restructuring [1]
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Globenewswire· 2026-03-12 11:55
Core Viewpoint - SciSparc Ltd. has announced an advancement in its collaboration with NeuroThera Labs Inc. for a novel combination therapy targeting weight loss and metabolic dysfunction-associated steatotic liver disease (MASLD) [1] Group 1: Company Overview - SciSparc Ltd. holds a controlling interest of approximately 75% in NeuroThera Labs Inc., which focuses on developing treatments for central nervous system disorders [1] - SciSparc is engaged in clinical-stage pharmaceutical developments, particularly in cannabinoid pharmaceuticals, with ongoing drug development programs targeting conditions such as Tourette syndrome, Alzheimer's disease, and autism spectrum disorder [4] Group 2: Collaboration and Patent Development - NeuroThera Labs has published an international patent application for a combination therapy involving 5-methoxy-2-aminoindane (MEAI) and Palmitoylethanolamide (PEA) [2] - The combination therapy aims to address obesity and MASLD, which affects over 890 million adults and approximately 30% of the global adult population, respectively [2] Group 3: Market Potential - The global weight loss drugs market was valued at approximately $37 billion in 2025 and is projected to reach $226 billion by 2035, driven by increasing awareness of obesity as a chronic disease [3] - The MEAI-PEA combination is expected to provide a safer and more cost-effective alternative to GLP-1 agonists for treating obesity and MASLD [2][3]
Calumet Announces $150 Million Private Placement of Additional 9.75% Senior Notes due 2031
Prnewswire· 2026-03-12 11:52
Core Viewpoint - Calumet, Inc. plans to conduct a private placement of $150 million in additional 9.75% Senior Notes due 2031 to repay outstanding borrowings under its revolving credit facility [1][1][1] Group 1: Offering Details - The offering will be made by Calumet's wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. [1] - The additional notes will be a further issuance of the existing 9.75% Senior Notes due 2031, of which $405 million was previously issued on January 12, 2026 [1][1] - The additional notes will have the same terms as the existing notes, except for the initial offering price [1] Group 2: Regulatory Information - The securities will not be registered under the Securities Act or any state securities laws and can only be offered to qualified institutional buyers and non-U.S. persons outside the United States [1][1] - The offering is subject to market conditions and will be conducted under Rule 144A and Regulation S of the Securities Act [1][1] Group 3: Company Overview - Calumet, Inc. manufactures, formulates, and markets a diverse range of specialty branded products and renewable fuels across various consumer and industrial markets [1] - The company is headquartered in Indianapolis, Indiana, and operates twelve facilities throughout North America [1]
Norsk Hydro's Qatar Aluminum Plant to Reduce Output Rather Than Fully Shutting Down
WSJ· 2026-03-12 11:52
Core Viewpoint - The Qatalum plant, a joint venture with QatarEnergy, will sustain aluminum production at approximately 60% of its total capacity [1] Company Summary - Qatalum is an equally owned joint venture with state-controlled QatarEnergy [1] - The plant's aluminum output is set to remain stable at around 60% of its total capacity [1]
Beamr to Demonstrate ML-Safe Video Data Compression for Physical AI at GTC 2026
Globenewswire· 2026-03-12 11:52
Core Insights - Beamr Imaging Ltd. is set to demonstrate a validated ML-safe video data compression technology for physical AI applications at GTC 2026, showcasing a reduction in file sizes by up to 50% while maintaining machine learning model accuracy [1][3]. Group 1: Technology and Innovation - Beamr's patented Content-Adaptive Bitrate (CABR) technology effectively addresses the challenges of video data compression, achieving up to 50% file size reduction while preserving model accuracy across various metrics [3]. - The company will collaborate with VAST Data to demonstrate GPU-accelerated video RAG/VSS solutions that enhance data ingestion processes while ensuring ML-safe results [4]. Group 2: Market Applications - Physical AI applications, such as autonomous vehicles and robotics, require efficient management of petabyte-scale video data, which is rapidly increasing in volume [2]. - Beamr's technology is particularly beneficial for industries managing large video datasets, including autonomous vehicles, media and entertainment, where video-language models facilitate efficient data curation [4]. Group 3: Company Background - Beamr is recognized as a leader in content-adaptive video compression, with a strong client base that includes major media companies like Netflix and Paramount, and is backed by 53 patents [6]. - The company offers flexible deployment options for its technology, including on-premises and cloud solutions, making it accessible for various customers, including those using AWS and Oracle Cloud Infrastructure [7].
Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71% Ni, 0.56% Cu Including 6.1 Metres of 1.17% Ni, 1.45% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario
TMX Newsfile· 2026-03-12 11:50
Core Viewpoint - Tartisan Nickel Corp. has provided an update on its Phase 1 diamond drill program at the Kenbridge Nickel-Copper-Cobalt Project, indicating significant high-grade mineralization results that enhance the potential of the Kenbridge Deposit [1][5]. Drilling Program Update - A total of 3,191 meters of drilling has been completed, with the first four drill targets successfully executed [2]. - The results from the fourth hole, KB26-210, confirmed the presence of both A and B zones, with significant mineralization reported [3]. Mineralization Results - Zone A was intersected from 762.4 to 787.0 meters, returning 0.71% Ni and 0.56% Cu over 24.6 meters, including higher-grade intervals of 1.17% Ni and 1.45% Cu over 6.1 meters, and 1.73% Ni and 0.31% Cu over 2.0 meters [3]. - Zone B was intersected from 800.2 to 806.0 meters, yielding 0.27% Ni and 0.24% Cu over 5.8 meters [3]. Future Plans - The company plans to introduce Borehole EM down the completed drill holes and commence Phase 2 drilling in the spring, aiming to explore deeper extensions of the deposit [5]. Project Location and Infrastructure - The Kenbridge Property is located in the Kenora Mining District, Sioux Narrows, Ontario, with all-season road access and an existing shaft reaching a depth of 2,042 feet (622 meters) [5]. Company Overview - Tartisan Nickel Corp. is a Canadian-based critical minerals exploration and development company, owning multiple projects including the Kenbridge Nickel-Copper Project [14]. - The company is listed on the Canadian Securities Exchange (CSE: TN) with 152,215,641 shares issued and outstanding [15].
Markets Doubt Trump's Iran Timeline. Wall Street's Bracing for a Long and Costly Iran War.
Barrons· 2026-03-12 11:48
Core Viewpoint - The narrative surrounding the conflict has shifted dramatically from expectations of a quick resolution to predictions of sustained high oil prices for an extended period, specifically a year [1] Group 1 - Investors' sentiment has changed from optimism about a swift end to the conflict to concerns about prolonged high oil prices [1]